Plasma Galectin-4 Levels Are Increased after Stroke in Mice and Humans
(2023) In International Journal of Molecular Sciences 24(12).- Abstract
- Epidemiological studies have associated plasma galectin-4 (Gal-4) levels with prevalent and incident diabetes, and with an increased risk of coronary artery disease. To date, data regarding possible associations between plasma Gal-4 and stroke are lacking. Using linear and logistic regression analyses, we tested Gal-4 association with prevalent stroke in a population-based cohort. Additionally, in mice fed a high-fat diet (HFD), we investigated whether plasma Gal-4 increases in response to ischemic stroke. Plasma Gal-4 was higher in subjects with prevalent ischemic stroke, and was associated with prevalent ischemic stroke (odds ratio 1.52; 95% confidence interval 1.01–2.30; p = 0.048) adjusted for age, sex, and covariates of... (More)
- Epidemiological studies have associated plasma galectin-4 (Gal-4) levels with prevalent and incident diabetes, and with an increased risk of coronary artery disease. To date, data regarding possible associations between plasma Gal-4 and stroke are lacking. Using linear and logistic regression analyses, we tested Gal-4 association with prevalent stroke in a population-based cohort. Additionally, in mice fed a high-fat diet (HFD), we investigated whether plasma Gal-4 increases in response to ischemic stroke. Plasma Gal-4 was higher in subjects with prevalent ischemic stroke, and was associated with prevalent ischemic stroke (odds ratio 1.52; 95% confidence interval 1.01–2.30; p = 0.048) adjusted for age, sex, and covariates of cardiometabolic health. Plasma Gal-4 increased after experimental stroke in both controls and HFD-fed mice. HFD exposure was devoid of impact on Gal-4 levels. This study demonstrates higher plasma Gal-4 levels in both experimental stroke and in humans that experienced ischemic stroke. (Less)
    Please use this url to cite or link to this publication:
    https://lup.lub.lu.se/record/8a6f58d8-3901-463b-95aa-dccbab7df5b8
- author
- 						Jujic, Amra
				LU
				 ; 						Vieira, João
				LU
	; 						Matuskova, Hana
				LU
	; 						Nilsson, Peter M
				LU
	; 						Lindblad, Ulf
	; 						Olsen, Michael H.
	; 						Duarte, Joao
				LU ; 						Vieira, João
				LU
	; 						Matuskova, Hana
				LU
	; 						Nilsson, Peter M
				LU
	; 						Lindblad, Ulf
	; 						Olsen, Michael H.
	; 						Duarte, Joao
				LU ; 						Meissner, Anja
				LU ; 						Meissner, Anja
				LU and 						Magnusson, Martin
				LU and 						Magnusson, Martin
				LU  
- organization
- 
                - EXODIAB: Excellence of Diabetes Research in Sweden
- Cardiovascular Research - Hypertension (research group)
- WCMM-Wallenberg Centre for Molecular Medicine
- MultiPark: Multidisciplinary research focused on Parkinson's disease
- Diabetes and Brain Function (research group)
- Department of Experimental Medical Science
- Internal Medicine - Epidemiology (research group)
- EpiHealth: Epidemiology for Health
- LU Profile Area: Proactive Ageing
- Vascular Biology (research group)
 
- publishing date
- 2023-05-13
- type
- Contribution to journal
- publication status
- published
- subject
- in
- International Journal of Molecular Sciences
- volume
- 24
- issue
- 12
- article number
- 10064
- publisher
- MDPI AG
- external identifiers
- 
                - pmid:37373212
- scopus:85163928982
 
- ISSN
- 1422-0067
- DOI
- 10.3390/ijms241210064
- language
- English
- LU publication?
- yes
- id
- 8a6f58d8-3901-463b-95aa-dccbab7df5b8
- date added to LUP
- 2023-06-13 12:07:20
- date last changed
- 2025-10-14 12:12:48
@article{8a6f58d8-3901-463b-95aa-dccbab7df5b8,
  abstract     = {{Epidemiological studies have associated plasma galectin-4 (Gal-4) levels with prevalent and incident diabetes, and with an increased risk of coronary artery disease. To date, data regarding possible associations between plasma Gal-4 and stroke are lacking. Using linear and logistic regression analyses, we tested Gal-4 association with prevalent stroke in a population-based cohort. Additionally, in mice fed a high-fat diet (HFD), we investigated whether plasma Gal-4 increases in response to ischemic stroke. Plasma Gal-4 was higher in subjects with prevalent ischemic stroke, and was associated with prevalent ischemic stroke (odds ratio 1.52; 95% confidence interval 1.01–2.30; p = 0.048) adjusted for age, sex, and covariates of cardiometabolic health. Plasma Gal-4 increased after experimental stroke in both controls and HFD-fed mice. HFD exposure was devoid of impact on Gal-4 levels. This study demonstrates higher plasma Gal-4 levels in both experimental stroke and in humans that experienced ischemic stroke.}},
  author       = {{Jujic, Amra and Vieira, João and Matuskova, Hana and Nilsson, Peter M and Lindblad, Ulf and Olsen, Michael H. and Duarte, Joao and Meissner, Anja and Magnusson, Martin}},
  issn         = {{1422-0067}},
  language     = {{eng}},
  month        = {{05}},
  number       = {{12}},
  publisher    = {{MDPI AG}},
  series       = {{International Journal of Molecular Sciences}},
  title        = {{Plasma Galectin-4 Levels Are Increased after Stroke in Mice and Humans}},
  url          = {{http://dx.doi.org/10.3390/ijms241210064}},
  doi          = {{10.3390/ijms241210064}},
  volume       = {{24}},
  year         = {{2023}},
}